ClinicalTrials.gg
Drug

Triamcinolone clinical trials

Also written Kenacort 40©.

Includes 194 studies of Triamcinolone Acetonide.

studies test it
291
open now
37
in phase 3
76
first study started
1993

How each study uses Triamcinolone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Triamcinolone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
3 Dec 1957 · ARISTOCORT · NDA 011161 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Triamcinolone
51
Kenalog
9
Triamcinolone Injection
4
Triamcinolone acetate
4
20mg triamcinolone
2

Brand

Kenacort 40©
2
Kenacort®
1

In one entry with another drug

Given together, or one or the other

triamcinolone and bevacizumab
2

Studies by the year they started

286 studies that test it; most in 2020 (22); 1 more planned to start later

Studies that test Triamcinolone, by start year
YearStudies
19931
20012
20022
20034
20047
200517
20068
20079
200811
20096
201012
20117
20128
201310
201412
201517
201613
201714
201812
201912
202022
20217
202211
202321
202413
202515
202613

By phase

A phase 1/2 study counts in both.

Early Phase 1
8
Phase 1
26
Phase 2
73
Phase 3
76
Phase 4
76
No phase
63

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 40 · Other 251

Pacira Pharmaceuticals, Inc (17) · Shahid Beheshti University of Medical Sciences (11) · Assiut University (9) · Clearside Biomedical, Inc. (7) · National Eye Institute (NEI) (6) · Al-Azhar University (5) · University of Sao Paulo (5) · Northwestern University (5)

Often tested with

Tested in the same studies.

Bevacizumab (20) · Dexamethasone (16) · Lidocaine (13) · Bupivacaine (10) · Methylprednisolone (6) · Fluorouracil (6) · Dexamethasone phosphate (4) · Dexmedetomidine (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 4 phase 3 studies under way

Triamcinolone is the comparator. A study of two new drugs counts under both.

  • 1Fluorouracil · Second Affiliated Hospital, School of Medicine, Zhejiang University
  • 1Ketorolac · Mayo Clinic · next primary completion Dec 2026
Reaching primary completion within a year · 20, 4 in phase 3

Studies that test Triamcinolone, phase 3 first.

Studies

Open first, then newest update. How each study uses Triamcinolone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 291

See all 291 studies that test Triamcinolone →

Given beside what is tested · 40 — Triamcinolone is usual care or a partner of the new treatment

Showing 20 of 40.

As the comparator · 93 — what is tested is compared with Triamcinolone

Showing 20 of 93.

Codes

What other systems call Triamcinolone · ClinicalTrials.gg INT008348

  • MeSH (NLM) D014221TriamcinoloneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 1ZK20VI6TYTRIAMCINOLONEConfirmed FDA, NLM, Wikidata
  • RxNorm 10759Confirmed FDA, Wikidata
  • Wikidata Q1074056triamcinoloneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C901TriamcinoloneOne source FDA
  • DrugBank DB00620One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.